Both in Pharmaceuticals
CDT Equity vs PMGC Holdings
Over the past year CDT returned −100.0% and ELAB returned −99.9%; their daily moves had a correlation of 0.03.
CDT −100.0% ELAB −99.9%Growth of $1, one year, split-adjusted
| Metric | CDT | ELAB |
|---|---|---|
| Price | $1.31 | $1.61 |
| Market cap | $1.3M | $1.3M |
| Today | −92.26% | −2.42% |
| 1 month | −91.8% | −48.5% |
| 6 months | −100.0% | −91.9% |
| Year to date | −100.0% | −99.5% |
| 1 year | −100.0% | −99.9% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 29.5% |
| Net margin | — | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | — | 0.5× |
| Net cash | -$390.0K | $9.4M |
| Dividend yield | — | — |
| Volatility (60d) | 1,261.4% | 678.1% |
| Short % of float | 18.8% | 0.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).